in past times number of years, the united kingdom has witnessed a revolution in clinical bodyweight‑reduction solutions — from the introduction of semaglutide (Wegovy®) towards the increasing acceptance of tirzepatide (Mounjaro®). Now, A further identify is drawing consideration in both equally c